▶주메뉴 바로가기

▶본문 바로가기

THE INVESTOR
February 21, 2020
Big Reunion

SEARCH

검색 폼

YOU SEARCHED FOR “Jung Hyun-ho”

Jung Hyun-ho

NET WORTH Updated Weekly

US$274M ▼ $544K
Jung Hyun-ho
  • BIRTH

    12/24/1962

  • CORPORATION

    Medytox

  • POSITION

    CEO (Founder)

  • EDUCATION

    KAIST Molecular Biology, Doctorate
    Seoul National University Microbiology

LISTED STOCK WEALTH

US$274M ▼ $544K

BIOGRAPHY

Jung was born in 1962. He studied microbiology at Seoul National University and earned his Ph.D. in molecular biology at KAIST. He was a professor at Sun Moon University when he lost government funding for his study on botulinum toxin due to the foreign exchange crisis.
Jung ventured into the biotechnology industry and founded Medytox, a R&D firm devoted to the deadly toxin used to manufacture Botox, a prescription medicine commonly known to improve – albeit temporarily -- the appearance of wrinkles.
After six years of R&D, he succeeded in manufacturing Medytox, a less expensive version of Botox. It was rejected as a generic at first, but slowly gained a reputation of its own.
In 2012, Allergan, a global leader in the industry and the creator of Botox, signed an estimated 390-billion-won-worth contract with Medytox for its new product in liquid form. Medytox is a dominant player in the domestic market as well, up to 40 percent in market share. It posted a total sale of 88.5 billion won in 2015.

EDITOR'S PICKS